Karyotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells

Taapken, Seth M, Nisler, Benjamin S, Newton, Michael A, Sampsell-Barron, Tori L, Leonhard, Kimberly A, McIntire, Erik M, Montgomery, Karen D·2011·Nature Biotechnology
DOI 10.1038/nbt.1835

Cited by (327)

Items 101–200 of 327

  1. Safeguarding clinical translation of pluripotent stem cells with suicide genes
    Weiqiang Li, Andy Peng Xiang · 2013 · Organogenesis
  2. Self-renewal and cell lineage differentiation strategies in human embryonic stem cells and induced pluripotent stem cells
    Anastasia G. Efthymiou, Guibin Chen, Mahendra S. Rao, Guokai Chen, Manfred Boehm · 2014 · Expert Opinion on Biological Therapy
  3. Clinical potential of human-induced pluripotent stem cells
    Dharmendra Kumar, Taruna Anand, Wilfried A. Kues · 2016 · Cell Biology and Toxicology
  4. The gene expression profiles of induced pluripotent stem cells from individuals with childhood cerebral adrenoleukodystrophy are consistent with proposed mechanisms of pathogenesis
    Wang, Xiao-Ming, Yik, Wing Yan, Zhang, Peilin, Lu, Wange, Dranchak, Patricia K, Shibata, Darryl, Steinberg, Steven J, Hacia, Joseph G · 2012 · Stem Cell Research & Therapy
  5. Ten years of iPSC: clinical potential and advances in vitro hematopoietic differentiation
    Bárbara Cristina Martins Fernandes Paes, Pablo Diego Moço, Cristiano Gonçalves Pereira, Geciâne Silveira Porto, Elisa Maria de Sousa Russo, Luiza Cunha Junqueira Reis, Dimas Tadeu Covas, Virgínia Picanço‐Castro · 2016 · Cell Biology and Toxicology
  6. A Comparative View on Easy to Deploy non-Integrating Methods for Patient-Specific iPSC Production
    Stefano Manzini, Leena E. Viiri, Suvi Marttila, Katriina Aalto‐Setälä · 2015 · Stem Cell Reviews and Reports
  7. The tumorigenic potential of pluripotent stem cells: What can we do to minimize it?
    Suzanne E. Peterson, Ibon Garitaonandia, Jeanne F. Loring · 2016 · BioEssays
  8. Cellular mechanisms underlying cardiac engraftment of stem cells
    Pushpinder Kanda, Darryl Raymond Davis · 2017 · Expert Opinion on Biological Therapy
  9. Chromosomal aberration arises during somatic reprogramming to pluripotent stem cells
    Xinyu Liu, Conghui Li, Kang Zheng, Xiaofeng Zhao, Xiaofeng Xu, Aifen Yang, Min Yi, Huaping Tao, Binghua Xie, Mengsheng S. Qiu et al. · 2020 · Cell Division
  10. Induced pluripotent stem cell technology: trends in molecular biology, from genetics to epigenetics.
    Amirhosein Maali, F. Maroufi, Farzin Sadeghi, A. Atashi, Reza Kouchaki, M. Moghadami, M. Azad · 2021 · Epigenomics
  11. A library of induced pluripotent stem cells from clinically well-characterized, diverse healthy human individuals
    Schaniel, Christoph, Dhanan, Priyanka, Hu, Bin, Xiong, Yuguang, Raghunandan, Teeya, Gonzalez, David M., Dariolli, Rafael, D'Souza, Sunita L., Yadaw, Arjun S., Hansen, Jens et al. · 2021 · Stem Cell Reports
  12. Cell surface markers for immunophenotyping human pluripotent stem cell-derived cardiomyocytes
    Kenneth R. Boheler, Ellen Ngar-Yun Poon · 2021 · Pflügers Archiv - European Journal of Physiology
  13. The Impact of Acquired Genetic Abnormalities on the Clinical Translation of Human Pluripotent Stem Cells
    Alexander Keller, Claudia Spits · 2021 · Cells
  14. Cellular reprogramming to reset epigenetic signatures
    Kyle J. Hewitt, Jonathan A. Garlick · 2012 · Molecular Aspects of Medicine
  15. Genome damage in induced pluripotent stem cells: Assessing the mechanisms and their consequences
    Samer M. I. Hussein, Judith Elbaz, András Nagy · 2012 · BioEssays
  16. TP53 promotes lineage commitment of human embryonic stem cells through ciliogenesis and sonic hedgehog signaling
    Sushama Sivakumar, Shutao Qi, Ningyan Cheng, Adwait Amod Sathe, Mohammed Kanchwala, Ashwani Kumar, Bret M. Evers, Chao Xing, Hongtao Yu · 2022 · Cell Reports
  17. Human iPS Cell-Derived Germ Cells: Current Status and Clinical Potential
    Tetsuya Ishii · 2014 · Journal of Clinical Medicine
  18. Consequences of trisomy 21 for brain development in Down syndrome
    Russo, Matthew L., Sousa, André M. M., Bhattacharyya, Anita · 2024 · Nature Reviews Neuroscience
  19. Generation of Functional Cardiomyocytes from Efficiently Generated Human iPSCs and a Novel Method of Measuring Contractility
    Sheeja Rajasingh, Jayakumar Thangavel, András Czirók, Saheli Samanta, Katherine F. Roby, Buddhadeb Dawn, Johnson Rajasingh · 2015 · PLoS ONE
  20. Methods of Reprogramming to Induced Pluripotent Stem Cell Associated with Chromosomal Integrity and Delineation of a Chromosome 5q Candidate Region for Growth Advantage
    Maria Sobol, Doroteya Raykova, Lucia B. Cavelier, Ayda Khalfallah, Jens Schuster, Niklas Dahl · 2015 · Stem Cells and Development
  21. Mitochondria in Human Pluripotent Stem Cell Apoptosis
    Tara A. TeSlaa, Kiyoko Setoguchi, M. Teitell · 2016 · Seminars in Cell and Developmental Biology
  22. Genomic Instability in Stem Cells: The Basic Issues
    Elio Antonio Prieto González, Khawaja Husnain Haider · 2021 · Springer eBooks
  23. Sex in cardiovascular disease: Why this biological variable should be considered in in vitro models
    Anna K. McClain, Peter Philip Monteleone, Janet Zoldan · 2024 · Science Advances
  24. Chromosomal aberrations after induced pluripotent stem cells reprogramming
    Isadora May Vaz, Tamara Borgonovo, Taís Hanae Kasai-Brunswick, Danúbia Silva dos Santos, Fernanda Mesquita, Juliana Ferreira Vasques, Fernanda Gubert, Cármen Lúcia Kuniyoshi Rebelatto, Alexandra Cristina Senegaglia, Paulo Roberto Slud Brofman · 2021 · Genetics and Molecular Biology
  25. Genomic instability, driver genes and cell selection: Projections from cancer to stem cells
    Uri Ben‐David · 2014 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
  26. Uncovering low-level mosaicism in human embryonic stem cells using high throughput single cell shallow sequencing
    Keller, Alexander, Tilleman, Laurentijn, Dziedzicka, Dominika, Zambelli, Filippo, Sermon, Karen, Van Nieuwerburgh, Filip, Spits, Claudia, Geens, Mieke · 2019 · Scientific Reports
  27. Implications of aneuploidy for stem cell biology and brain therapeutics
    Sylvie Devalle, Rafaela Sartore, Bruna S. Paulsen, Helena L. Borges, Rodrigo A. P. Martins, Stevens Kastrup Rehen · 2012 · Frontiers in Cellular Neuroscience
  28. Genome stability of programmed stem cell products
    Ulrich Martin · 2017 · Advanced Drug Delivery Reviews
  29. Utilizing induced pluripotent stem cells (iPSCs) to understand the actions of estrogens in human neurons
    Carole Shum, Sara C. Macedo, Katherine M. Warre-Cornish, Graham D. Cocks, Jack Price, Deepak P. Srivastava · 2015 · Hormones and Behavior
  30. Complex biology of constitutional ring chromosomes structure and (in)stability revealed by somatic cell reprogramming
    Nikitina Tv, А. А. Кашеварова, Maria M. Gridina, М. Е. Лопаткина, Anna A. Khabarova, Yu. S. Yakovleva, Aleksei G. Menzorov, Yu. A. Minina, Inna E. Pristyazhnyuk, S. А. Vasilyev et al. · 2021 · Scientific Reports
  31. Induced pluripotent stem cell models of Zellweger spectrum disorder show impaired peroxisome assembly and cell type-specific lipid abnormalities
    Xiao Ming Wang, Wing Yan Yik, Peilin Zhang, Wange Lu, Ning Huang, Bo Ram Kim, Darryl K. Shibata, Madison Zitting, Robert Hsiu-Ping Chow, Ann B. Moser et al. · 2015 · Stem Cell Research & Therapy
  32. Increased Genomic Integrity of an Improved Protein-Based Mouse Induced Pluripotent Stem Cell Method Compared With Current Viral-Induced Strategies
    Hansoo Park, Dohoon Kim, Chun‐Hyung Kim, Ryan E. Mills, Mi‐Yoon Chang, Rebecca C. Iskow, Sanghyeok Ko, Jung-Il Moon, Hyun Woo Choi, Paulo Sng Man Yoo et al. · 2014 · Stem Cells Translational Medicine
  33. Single Cell Analysis Reveals the Stochastic Phase of Reprogramming to Pluripotency Is an Ordered Probabilistic Process
    Kyung-Min Chung, Frederick W. Kolling, Matthew D. Gajdosik, Steven Burger, Alexander C. Russell, Craig E. Nelson · 2014 · PLoS ONE
  34. Stem Cell-Derived Neurons as Cellular Models of Sporadic Alzheimer’s Disease
    Bénédicte Foveau, Ana Sofia Correia, Sébastien S. Hébert, Sara Rainone, Olivier Potvin, Marie‐Jeanne Kergoat, Sylvie Belleville, Simon Duchesne, Andrea Claire LeBlanc · 2019 · Journal of Alzheimer s Disease
  35. Patient-specific Induced Pluripotent Stem Cells as a Platform for Disease Modeling, Drug Discovery and Precision Personalized Medicine
    Wilson Young · 2012 · Journal of Stem Cell Research & Therapy
  36. Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency
    Naofumi Ito, Kaoru Katoh, Hiroko Kushige, Yutaka Saitō, Terumasa Umemoto, Yu Matsuzaki, Hiroshi Kiyonari, Daiki Kobayashi, Minami Soga, Takumi Era et al. · 2018 · Scientific Reports
  37. Aberrant hiPSCs-Derived from Human Keratinocytes Differentiates into 3D Retinal Organoids that Acquire Mature Photoreceptors
    Rupendra Shrestha, Yao‐Tseng Wen, Dah‐Ching Ding, Rong‐Kung Tsai · 2019 · Cells
  38. Medicinal Biotechnology for Disease Modeling, Clinical Therapy, and Drug Discovery and Development
    Robin Duelen, Marlies Corvelyn, Ilaria Tortorella, Leonardo Leonardi, Yoke Chin Chai, Maurilio Sampaolesi · 2019 · Springer eBooks
  39. Transition from Animal-Based to Human Induced Pluripotent Stem Cells (iPSCs)-Based Models of Neurodevelopmental Disorders: Opportunities and Challenges
    Sara R. Guerreiro, Patrı́cia Maciel · 2023 · Cells
  40. Feeder-free culture of human pluripotent stem cells drives MDM4-mediated gain of chromosome 1q
    Dylan Stavish, Christopher J. Price, Gabriele Gelezauskaite, Haneen Alsehli, Kimberly A. Leonhard, Seth M. Taapken, Erik M. McIntire, Owen Laing, Bethany M. James, Jack J. Riley et al. · 2024 · Stem Cell Reports
  41. CRISPR/Cas9‐based Targeted Genome Editing for the Development of Monogenic Diseases Models with Human Pluripotent Stem Cells
    Navin R. Gupta, Koichiro Susa, Yoko Yoda, Joseph Vincent Bonventre, M. Todd Valerius, Ryuji Morizane · 2018 · Current Protocols in Stem Cell Biology
  42. Academic application of Good Cell Culture Practice for induced pluripotent stem cells
    Julia Tigges · 2021 · ALTEX
  43. Reprogramming of human cells to pluripotency induces CENP-A chromatin depletion
    Inês Milagre, Carolina A. Pereira, Raquel A. Oliveira, Lars E.T. Jansen · 2020 · Open Biology
  44. Dual Mode of Mitochondrial ROS Action during Reprogramming to Pluripotency
    Elena V. Skvortsova, Igor B. Nazarov, Alexey N. Tomilin, Sergey A. Sinenko · 2022 · International Journal of Molecular Sciences
  45. A Scaled Framework for CRISPR Editing of Human Pluripotent Stem Cells to Study Psychiatric Disease
    Dane Z. Hazelbaker, Amanda Beccard, Anne M. Bara, Nicole Dabkowski, Angelica Messana, Patrizia Mazzucato, Daisy Lam, Danielle K. Manning, Kevin C. Eggan, Lindy E. Barrett · 2017 · Stem Cell Reports
  46. Cellular reprogramming: a novel tool for investigating autism spectrum disorders
    Kun‐Yong Kim, Yong Wook Jung, Gareth J. Sullivan, Leeyup Chung, In‐Hyun Park · 2012 · Trends in Molecular Medicine
  47. The isochromosome 20q abnormality of pluripotent cells interrupts germ layer differentiation
    Loriana Vitillo, Fabiha Anjum, Zoë Hewitt, Dylan Stavish, Owen Laing, Duncan Baker, Ivana Barbaric, Peter J. Coffey · 2023 · Stem Cell Reports
  48. Gains of 20q11.21 in human pluripotent stem cells: Insights from cancer research
    Nuša Krivec, Manjusha S. Ghosh, Claudia Spits · 2023 · Stem Cell Reports
  49. Ultra-High-Frequency Reprogramming of Individual Long-Term Hematopoietic Stem Cells Yields Low Somatic Variant Induced Pluripotent Stem Cells
    Kai Wang, Anthony K. Guzman, Zi Yan, Shouping Zhang, Michael Y. Hu, Mehdi Bagheri Hamaneh, Yi‐Kuo Yu, Seda Serra Tolu, Jinghang Zhang, Holly E. Kanavy et al. · 2019 · Cell Reports
  50. The application of an in situ karyotyping technique for mesenchymal stromal cells: a validation and comparison study with classical G-banding
    Sang Mee Hwang, Cha Ja See, Jungeun Choi, Seon Young Kim, Qute Choi, Jung Ah Kim, Jiseok Kwon, Si Nae Park, Kyongok Im, Il‐Hoan Oh et al. · 2013 · Experimental & Molecular Medicine
  51. Nuclear reprogramming with a non-integrating human RNA virus
    Christopher B. Driscoll, Jason M. Tonne, Moustafa M. El Khatib, Roberto Cattaneo, Yasuhiro Ikeda, Patricia Devaux · 2015 · Stem Cell Research & Therapy
  52. Aneuploidy is permissive for hepatocyte-like cell differentiation from human induced pluripotent stem cells
    Fallon K. Noto, Megan R. Determan, Jun Cai, Max A. Cayo, Sunil K. Mallanna, Stephen A. Duncan · 2014 · BMC Research Notes
  53. Somatic cell reprogramming for regenerative medicine: SCNT vs. iPS cells
    Guangjin Pan, Tao Wang, Hongjie Yao, Duanqing Pei · 2012 · BioEssays
  54. Reprogramming to pluripotency can conceal somatic cell chromosomal instability
    Hamada, Masakazu, Malureanu, Liviu A., Wijshake, Tobias, Zhou, Wei, van Deursen, Jan M. · 2012 · PLoS Genetics
  55. Effective Differentiation and Biological Characterization of Retinal Pigment Epithelium Derived from Human Induced Pluripotent Stem Cells
    Rupendra Shrestha, Yao‐Tseng Wen, Rong‐Kung Tsai · 2020 · Current Eye Research
  56. Cell Reprogramming to Model Huntington’s Disease: A Comprehensive Review
    Ruth Monk, Bronwen J. Connor · 2021 · Cells
  57. Induced Pluripotent Stem Cells for Inherited Optic Neuropathies—Disease Modeling and Therapeutic Development
    Joshua Paul Harvey, Paul E. Sladen, Patrick Yu‐Wai‐Man, Michael E. Cheetham · 2021 · Journal of Neuro-Ophthalmology
  58. Standardized Quality Control Workflow to Evaluate the Reproducibility and Differentiation Potential of Human iPSCs into Neurons
    Carol X.‐Q. Chen, Narges Abdian, Gilles Maussion, Rhalena A. Thomas, Iveta Demirova, Eddie Cai, Mahdieh Tabatabaei, Lenore K. Beitel, Jason Karamchandani, Edward A. Fon et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  59. Dynamic Features of Chromosomal Instability during Culture of Induced Pluripotent Stem Cells
    Casey O. DuBose, John R. Daum, Christopher L. Sansam, Gary J. Gorbsky · 2022 · Genes
  60. Single Nucleotide Polymorphism (SNP) Arrays and Their Sensitivity for Detection of Genetic Changes in Human Pluripotent Stem Cell Cultures
    Victoria Steventon‐Jones, Dylan Stavish, Jason Alexander Halliwell, Duncan Baker, Ivana Barbaric · 2022 · Current Protocols
  61. Neutrophil generation from hematopoietic progenitor cells and induced pluripotent stem cells (iPSCs): potential applications
    Abdollah Jafarzadeh, Marzieh Motaghi, Sananda Kumar Patra, Zahra Jafarzadeh, Maryam Nemati, Bhaskar Saha · 2024 · Cytotherapy
  62. Reprogramming of Adult Peripheral Blood Cells into Human Induced Pluripotent Stem Cells as a Safe and Accessible Source of Endothelial Cells
    Pavel Šimara, Lenka Tesařová, Daniela Řeháková, Šimon Farkaš, Barbara Šalingová, Kateřina Kutálková, Eva Vavrečková, Pavel Matula, Petr Matula, Lenka Veverková et al. · 2017 · Stem Cells and Development
  63. Induced Pluripotent Stem Cells for Inherited Optic Neuropathies—Disease Modeling and Therapeutic Development
    Harvey, JP, Sladen, PE, Patrick Yu‐Wai‐Man, Michael E. Cheetham · 2022 · UCL Discovery (University College London)
  64. Potential applications of keratinocytes derived from human embryonic stem cells
    Mohammad Mehdi Movahednia, Fahad Karim Kidwai, Doorgesh Sharma Jokhun, Christopher A. Squier, Wei Seong Toh, Tong Cao · 2015 · Biotechnology Journal
  65. Inactivation of PLK4-STIL Module Prevents Self-Renewal and Triggers p53-Dependent Differentiation in Human Pluripotent Stem Cells
    Tereza Renzová, Dáša Bohačiaková, Milan Ešner, Veronika Pospíšilová, Tomáš Bárta, Aleš Hampl, Lukáš Čajánek · 2018 · Stem Cell Reports
  66. A pluripotent developmental state confers a low fidelity of chromosome segregation
    Chenhui Deng, Amanda Ya, Duane A. Compton, Kristina M. Godek · 2023 · Stem Cell Reports
  67. Chemical Reversion of Conventional Human Pluripotent Stem Cells to a Naïve-like State with Improved Multilineage Differentiation Potency
    Tea Soon Park, Ludovic Zimmerlin, Rebecca Evans-Moses, Elias T. Zambidis · 2018 · Journal of Visualized Experiments
  68. Aneuploidy in stem cells
    Jorge García–Martínez, Björn Bakker, Klaske M. Schukken, Judith E. Simon, Floris Foijer · 2016 · World Journal of Stem Cells
  69. Investigating the role of Sirtuins in cell reprogramming
    Jaein Shin, Junyeop Kim, Hanseul Park, Jongpil Kim · 2018 · BMB Reports
  70. A Dishful of a Troubled Mind: Induced Pluripotent Stem Cells in Psychiatric Research
    Sára Kálmán, Edit Hathy, János Réthelyi · 2015 · Stem Cells International
  71. Gene-repaired iPS cells as novel approach for patient with osteogenesis imperfecta
    Agnieszka Fus-Kujawa, Barbara Mendrek, Karolina Bajdak-Rusinek, Natalia Diak, Karolina Strzelec, Ewa Gutmajster, Kamil Janelt, Agnieszka Kowalczuk, Anna Trybus, Patrycja Rozwadowska et al. · 2023 · Frontiers in Bioengineering and Biotechnology
  72. A dynamic in vitro model of Down syndrome neurogenesis with trisomy 21 gene dosage correction
    Bansal, Prakhar, Banda, Erin C., Glatt-Deeley, Heather R., Stoddard, Christopher E., Linsley, Jeremy W., Arora, Neha, Deleschaux, Cécile, Ahern, Darcy T., Kondaveeti, Yuvabharath, Massey, Rachael E. et al. · 2024 · Science Advances
  73. Potential for pharmacological manipulation of human embryonic stem cells
    Stuart P. Atkinson, Majlinda Lako, Lyle Armstrong · 2012 · British Journal of Pharmacology
  74. Immunogenicity of β-cells for autologous transplantation in type 1 diabetes
    Christian Schuetz, James F. Markmann · 2015 · Pharmacological Research
  75. Bioreactor-Based Bone Tissue Engineering
    Inga Marijanović, Maja Antunović, Igor Matić, Marina Panek, Alan Ivković · 2016 · InTech eBooks
  76. Acquired Genetic and Epigenetic Variation in Human Pluripotent Stem Cells
    O. Kyriakides, Jason Alexander Halliwell, Peter W. Andrews · 2017 · Advances in biochemical engineering, biotechnology
  77. Nonintegrating Human Somatic Cell Reprogramming Methods.
    T. Schlaeger · 2018 · Advances in Biochemical Engineering/Biotechnology
  78. SALL3 mediates the loss of neuroectodermal differentiation potential in human embryonic stem cells with chromosome 18q loss
    Yingnan Lei, Diana Al Delbany, Nuša Krivec, Marius Regin, Edouard Couvreu de Deckersberg, Charlotte Janssens, Manjusha S. Ghosh, Karen Sermon, Claudia Spits · 2024 · Stem Cell Reports
  79. Culture‐acquired genetic variation in human pluripotent stem cells: Twenty years on
    John P. Vales, Ivana Barbaric · 2024 · BioEssays
  80. Protocol for the Growth and Maturation of hiPSC‐Derived Kidney Organoids using Mechanically Defined Hydrogels
    Ivan Krupa, Niall J. Treacy, Shane Clerkin, Jessica L. Davis, Aline F. Miller, Alberto Saiani, Jacek Kamil Wychowaniec, Emmanuel G. Reynaud, Dermot F. Brougham, John K. G. Crean · 2024 · Current Protocols
  81. Copy number variations (CNVs) in human pluripotent cell-derived neuroprogenitors
    Nestor L. Lopez-Corrales, Kristin Mrasek, Martin Voigt, Thomas Liehr, Nadezda Kosyakova · 2012 · Gene
  82. Deep Sequencing Reveals Low Incidence of Endogenous LINE-1 Retrotransposition in Human Induced Pluripotent Stem Cells
    Hubert Arokium, Masakazu Kamata, Sanggu Kim, Namshin Kim, Min Liang, Angela P. Presson, Irvin S. Y. Chen · 2014 · PLoS ONE
  83. A RHO Small GTPase Regulator ABR Secures Mitotic Fidelity in Human Embryonic Stem Cells
    Masatoshi Ohgushi, Maki Minaguchi, Mototsugu Eiraku, Yoshiki Sasai · 2017 · Stem Cell Reports
  84. Standardization of Cell Culture Conditions and Routine Genomic Screening under a Quality Management System Leads to Reduced Genomic Instability in hPSCs
    Francisco J. Molina-Ruiz, Clelia Introna, Georgina Bombau, Mireia Galofré, Josep Maria Canals · 2022 · Cells
  85. Requirements for Using iPSC-Based Cell Models for Assay Development in Drug Discovery
    Klaus Christensen, Filip Roudnicky, Christoph Patsch, Mark M. Burcin · 2017 · Advances in biochemical engineering, biotechnology
  86. Concise Review: Methods and Cell Types Used to Generate Down Syndrome Induced Pluripotent Stem Cells
    Youssef Hibaoui, Anis Féki · 2015 · Journal of Clinical Medicine
  87. Karyotypically abnormal human ESCs are sensitive to HDAC inhibitors and show altered regulation of genes linked to cancers and neurological diseases
    Riikka Lund, Maheswarareddy Emani, Ivana Barbaric, Virpi Kivinen, Mark Jones, Duncan Baker, Paul J. Gokhale, Matti Nykter, Riitta Lahesmaa, Peter W. Andrews · 2013 · Stem Cell Research
  88. The Winding Road of Cardiac Regeneration—Stem Cell Omics in the Spotlight
    Miruna Mihaela Micheu, Alina Ioana Scărlătescu, Alexandru Scafa‐Udriște, Maria Dorobanţu · 2018 · Cells
  89. Tracking cell lineages to improve research reproducibility
    Sophie Zaaijer, Simon Cornelis Groen, Neville E. Sanjana · 2021 · Nature Biotechnology
  90. The Regenerative Microenvironment of the Tissue Engineering for Urethral Strictures
    Wenyuan Leng, Xiaoyu Li, L. Dong, Zhenke Guo, X. Ji, Tian-Yu Cai, Chun-Ru Xu, Zhen-Peng Zhu, Jian Lin · 2024 · Stem Cell Reviews and Reports
  91. A systems view of cellular heterogeneity: Unlocking the “wheel of fate”
    Hourieh Movasat, Enzo Giacopino, Ali Shahdoost, Yeganeh Dorri Nokoorani, Ali Houshyar Abrbekouh, Yaser Tahamtani, Nika Shakiba · 2025 · Cell Systems
  92. Review: Induced pluripotent stem cell models of frontotemporal dementia
    Elisavet Preza, John Hardy, Thomas T. Warner, Selina Wray · 2016 · Neuropathology and Applied Neurobiology
  93. Preparation, characterization, and banking of clinical-grade cells for neural transplantation
    Ammar Natalwala, Tilo Kunath · 2017 · Progress in brain research
  94. Copy number variant hotspots in Han Taiwanese population induced pluripotent stem cell lines - lessons from establishing the Taiwan human disease iPSC Consortium Bank
    Ching-Ying Huang, Ling-Hui Li, Wan-Tseng Hsu, Yu‐Che Cheng, Martin W. Nicholson, Chun-Lin Liu, Chien-Yu Ting, Hui-Wen Ko, Shih‐Han Syu, Cheng-Hao Wen et al. · 2020 · Journal of Biomedical Science
  95. G-Banded Karyotyping of Human Pluripotent Stem Cell Cultures
    Erik M. McIntire, Kimberly Leonhard, Seth M. Taapken, Anna Lisa Larson · 2020 · Methods in molecular biology
  96. Chromosome microduplication in somatic cells decreases the genetic stability of human reprogrammed somatic cells and results in pluripotent stem cells
    Yang Yu, Liang Chang, Hongcui Zhao, Rong Li, Yong Fan, Jie Qiao · 2015 · Scientific Reports
  97. High‐Fidelity Reprogrammed Human IPSCs Have a High Efficacy of DNA Repair and Resemble hESCs in Their MYC Transcriptional Signature
    Pratik K. Nagaria, Carine Robert, Tea Soon Park, Jeffrey S. Huo, Elias T. Zambidis, Feyruz Virgilia Rassool · 2016 · Stem Cells International
  98. Cellular Models: HD Patient-Derived Pluripotent Stem Cells
    Charlene Smith-Geater, Sarah J. Hernandez, Leslie Michels Thompson, Virginia B. Mattis · 2018 · Methods in molecular biology
  99. Generation of iPSC lines with high cytogenetic stability from peripheral blood mononuclear cells (PBMCs)
    Lindsay Panther, Loren Ornelas, Michelle R. Jones, Andrew R. Gross, Emilda Gomez, Chunyan Liu, Benjamin P. Berman, Clive Niels Svendsen, Dhruv Sareen · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  100. Mitophagy is induced in human engineered heart tissue after simulated ischemia and reperfusion
    Mireia Nàger, Kenneth Bowitz Larsen, Zambarlal Bhujabal, Trine Kalstad, Judith Rössinger, Truls Myrmel, Florian Weinberger, Åsa Birna Birgisdottir · 2025 · Journal of Cell Science